Industry news

Russia may enact its register of interchangeable medicines from January 1, 2019

GMP News

Russian Ministry of Health completed its work on the bill to amend the Federal Law “On Circulation of Medicines” which provides, in particular, for the establishment of a register of interchangeable drugs. It may be enacted from January 1, 2019. The public discussion of the bill will continue until May 14. In addition, it should be approved by the Federal Antimonopoly Service (FAS).

Restless R&D executives, and a few FDA staffers, on the move to rival pharmas

Ben Adams / FierceBiotech

There are only so many things you can do as a pharma R&D executive when you start to get a little grim about the mouth, or whenever you feel a drizzly November in your soul: you go to sea, jumping ship into young biotechs, or sail out into the new world of venture capitalism. Many are lured by the siren call of “raw science” and being on the new wave of innovation, although many will face the prospect of being dashed onto the rocks (see: David Hung’s call to Axovant).

India aims to stimulate local API manufacturing

GMP News

In a bid to reduce India’s dependence on China for active pharmaceutical ingredients (APIs), the chemicals and fertilizers Indian Ministry of Chemicals and Fertilizers has joined hands with other ministries to draw up a road map for increasing their production in the country.

Kaluga pharmaceutical cluster shows growth and increase in localization level

GMP News

According to the Governor of Kaluga region Anatoly Artamonov, Kaluga pharmaceutical cluster achieved significant results over the seven years of its existence. This period was marked by a five-fold increase in the output. For 2017, the industrial production index of the sector reached 167%.

Participants of Russian industrial clusters will receive subsidies

GMP News

Pharmaceutical companies participating in an industrial cluster can receive subsidies for up to 50% of their costs incurred for the implementation of joint cluster projects. This was announced by Andrey Shpilenko, Director of the Association of Clusters and Technology Parks.

24 April 2018

Evofem Biosciences Announces Proposed Public Offering of Common Stock

Evofem Biosciences, Inc., (NASDAQ: EVFM) ("Evofem" or the "Company"), a clinical-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, announced today the launch of an underwritten public offering of $40.0 million of its common stock. All of the shares in the offering are to be sold by Evofem.

St. Petersburg SEZ may receive seven new pharma production facilities in 2018

GMP News

Seven new pharmaceutical enterprises will be established in Neudorf and Novoorlovskaya sites of St. Petersburg Special Economic Zone (SEZ) by the end of 2018.

30 pharmaceutical production sites were opened in Russia since 2013

GMP News

The Russian Ministry of Industry and Trade released a Report on Main Results of the Ministry of Industry and Trade of the Russian Federation in 2017. Among other things, this document describes the goals and objectives achieved by the Russian pharmaceutical industry in the recent period.

New tech aims at faster eyesight recuperation

Marchmont Innovation News

A collaborative team of researchers in the Lower Volga area, comprising scientists from the Samara University and medical practitioners from the local Research Institute for Eye Diseases, has developed a new method of preventing postsurgical complications in ophthalmology patients. 
 

Siberians work to make implants last long

Marchmont Innovation News

Researchers at the Tomsk State University (TSU) in Siberia have developed a new method of improving the survival of implants used for oral and maxillofacial surgery and in dentistry.